Metraipolis › archive › dc_cb906eb80d67

Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial — Europe PMC PMID:41837971

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41837971
DOI
10.1001/jamainternmed.2026.0057
License (as archived)
solo-consultazione
Archived
2026-11-02T22:25:32.060Z
SHA-256 of the archived text
5d64bed2d8c25454d5a484bee56e1a06ad40b88c27817385e77676c4ff28d43e
Stable URL of this page
https://metraipolis.com/documento/dc_cb906eb80d67

How to cite

Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial — Europe PMC PMID:41837971 — Europe PMC (en), https://europepmc.org/article/MED/41837971 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb906eb80d67 (Metraipolis archive dc_cb906eb80d67, sha256 5d64bed2d8c25454d5a484bee56e1a06ad40b88c27817385e77676c4ff28d43e)
BibTeX
@misc{dccb906eb80d67,
  title = {Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial — Europe PMC PMID:41837971},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41837971},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb906eb80d67; sha256 5d64bed2d8c25454d5a484bee56e1a06ad40b88c27817385e77676c4ff28d43e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41837971. Agents can read the archived copy with the MCP tool read_document.